Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Spectacular Images Showing Research into Cancer, Neurodegenerative Disease and Fertility

Published: Wednesday, March 12, 2014
Last Updated: Wednesday, March 12, 2014
Bookmark and Share
Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore announced as the winners of the GE Healthcare 2013 Cell Imaging Competition.

With over 23,000 votes cast by the public, the winners can now look forward to seeing their prize-winning images lighting up Times Square, New York at a special event between 25-27 April 2014.

For seven years, GE Healthcare’s annual competition has showcased the beauty of cells and the inspiring research of cellular biologists from around the world.   This year’s competition attracted over 100 entries from scientists who are using either high-content analysis or high- and super resolution microscopy to investigate at the cellular level a wide variety of diseases such as cancer, muscle disease and the effects of parasitic infections.

An expert scientific panel of six judges* shortlisted the finalists for each category ahead of the public vote. The full details of the three winners are:

1st place - Microscopy category


Vanessa Auld, University of British Columbia, Vancouver, Canada.

Image description: Drosophila neuromuscular junction stained for extracellular matrix proteins (green and blue) and the nerve terminal (red).

Therapeutic focus: Neurodegenerative disease.

1st place – High-Content Analysis category


Martin Barr, St James’s Hospital and Trinity College Dublin, Dublin, Ireland.

Image description: Lung adenocarcinoma cell stained for F-actin (green), mitochondria (red) and DNA (blue).

Therapeutic focus: Cancer.

Regional winner (Microscopy category)


Graham Wright, Institute of Medical Biology, A*STAR, Singapore

Image description: Mouse spermatocyte spread stained for KASH-5 and SCP3 (red and green) and DNA (blue).

Therapeutic focus: Fertility.

Eric Roman, General Manager of Research and Applied Markets, GE Healthcare Life Sciences, said:

“This year’s three winning images are once again incredibly beautiful and compelling, reminding us of the cellular complexity behind disease and why the study of cells is so important.  We were delighted to receive so many outstanding entries to the competition, which highlights how cell imaging is helping scientists explore the universe of the cell and is advancing our understanding of so many life-threatening and life-limiting diseases. I’d like to thank all the contestants for sending us their images, the judging panel and everyone who cast a vote.”

The winning images and gallery of all the finalists’ entries to the 2013 Cell Imaging Competition are available at

*This year’s shortlist was selected by Paul Goodwin, Science Director, Cellular Imaging and Analysis at GE Healthcare; Geoffrey Grandjean, Sanford Burnham Medical Research Institute, California and 2011 competition winner for the Americas; Julian P. Heath, Editor of Microscopy & Analysis; Carmen Laethem, Scientist and Project Manager, Aerie Pharmaceuticals; Kristie Nybo, Assistant Editor, BioTechniques and Nick Thomas, Principal Scientist at GE Healthcare.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences to Create New US Headquarters
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.
Wednesday, August 20, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos